Hypertension is a global health crisis and is the leading cause of morbidity and mortality.  Controlling hypertension is the top health priority in the United States and worldwide:

The Surgeon General’s Call to Action to Control Hypertension reports that hypertension widely affects nearly half of the U.S. adult population and is the leading cause of morbidity and mortality.

The 2023 World Health Organization Report on Hypertension estimates that 1.3 billion adults worldwide suffer from hypertension.

Nearly half of adults have hypertension, and only a fourth with hypertension have it under control. This places millions of Americans at the heightened risk of devastating effects of hypertension, including heart disease, stroke, kidney failure, and other leading causes of death in the United States.


The time to act is now.


The Surgeon General’s Call to Action to Control Hypertension


Qura revolutionizes blood pressure monitoring with one of the world's smallest implantable devices, called QSmart™.


QSmart collects continuously transmitted patient data that can be acted upon in real-time and analyzed using AI to generate predictive analytics. This provides a better understanding of a patient's blood pressure status and trends, greatly improves the care of patients with uncontrolled hypertension, and drives greatly enhanced therapeutic decision making. 


Qura’s approach broadly facilitates the patient and caregiver experience by improving efficiency and effectiveness of managing hypertension, while reducing the overall cost of care.

Uncontrolled hypertension can result in heart attacks, strokes, and premature death, along with substantial economic losses for communities and countries.  It drives and worsens virtually all chronic disease.


The biggest challenge in managing hypertension today is obtaining accurate, continuous, and actionable blood pressure data transmitted effortlessly from the patient to the physician. Better links between patient and physician are best accomplished through the integrated use of new health technologies and data systems available and accessible to broader populations.